Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#2 Fake World Assets Fake World Assets +18.28%
#3 Status Status +17.90%
#4 GoPlus Security GoPlus Security +11.51%
#5 Ontology Gas Ontology Gas +10.01%
#6 Bedrock Bedrock +7.70%
#7 DMT-NAT DMT-NAT +7.61%
#8 Cap Cap +6.73%
#9 Provenance Blockchain Provenance Blockchain +6.73%
#10 Janction Janction +5.45%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Xếp hạng trong cổ phiếu #33997
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Giá cổ phiếu
$0.1502
Đồng bộ lần cuối: 2024-11-04
Vốn hóa thị trường
$6.43M
Thay đổi (1 ngày)
-5.45%
Thay đổi (1 năm)
0.00%
Quốc gia
US
Giao dịch Renalytix Plc (RNLX)

Danh mục

Healthcare
Tỷ lệ P/B của Renalytix Plc (RNLX)
Tỷ lệ P/B vào August 2026 TTM: -1.43
Theo các báo cáo tài chính và giá cổ phiếu mới nhất của Renalytix Plc, tỷ lệ P/B hiện tại (TTM) là -1.43. Vào cuối năm 2023, công ty có P/B là 6.50.
Lịch sử tỷ lệ P/B của Renalytix Plc từ 2018 đến 2026
Tỷ lệ P/B vào cuối mỗi năm
Năm Tỷ lệ P/B Thay đổi
2026 (TTM) -1.43 -17.55%
2024 -1.73 -126.57%
2023 6.50 237.16%
2022 1.93 -83.22%
2021 11.50 5.79%
2020 10.87 6.56%
2019 10.20 -100.03%
2018 -30.05K 0.00%
Tỷ lệ P/B của các công ty tương tự hoặc đối thủ cạnh tranh
Công ty Tỷ lệ P/B Chênh lệch Tỷ lệ P/B Quốc gia
GE HealthCare Technologies Inc. GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
GEHC.US
 3.0416 -313.25%
US
Pro Medicus Limited Pro Medicus Limited
Pro Medicus Limited
PME.AX
 48.0487 -3,468.77%
AU
BrightSpring Health Services, Inc. Common Stock BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock
BTSG.US
 6.2063 -535.13%
US
Tempus AI, Inc. Tempus AI, Inc.
Tempus AI, Inc.
TEM.US
 21.0676 -1,577.08%
US
Signify Health, Inc. Signify Health, Inc.
Signify Health, Inc.
SGFY.US
 - -
US